Megasoft Ltd
Incorporated in 1999, Megasoft Ltd is
in the business of providing Telecom
services[1]
- Market Cap ₹ 537 Cr.
- Current Price ₹ 72.8
- High / Low ₹ 107 / 28.6
- Stock P/E 52.0
- Book Value ₹ 27.5
- Dividend Yield 0.00 %
- ROCE 7.68 %
- ROE 5.48 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 32.7% CAGR over last 5 years
Cons
- Stock is trading at 2.66 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -41.4% over past five years.
- Tax rate seems low
- Company has a low return on equity of 2.83% over last 3 years.
- Earnings include an other income of Rs.40.8 Cr.
- Working capital days have increased from 1,716 days to 6,398 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50 | 46 | 51 | 51 | 29 | 31 | 29 | 24 | 20 | 16 | 14 | 2 | 0 | |
44 | 41 | 43 | 45 | 26 | 35 | 31 | 28 | 19 | 16 | 33 | 20 | 10 | |
Operating Profit | 6 | 5 | 8 | 6 | 3 | -4 | -3 | -5 | 1 | 1 | -18 | -18 | -10 |
OPM % | 12% | 11% | 15% | 11% | 11% | -14% | -9% | -20% | 6% | 4% | -131% | -898% | |
7 | 3 | 4 | 1 | 1 | 8 | 1 | 10 | 6 | 7 | 30 | 43 | 41 | |
Interest | 3 | 3 | 5 | 3 | 2 | 2 | 3 | 4 | 4 | 3 | 2 | 11 | 17 |
Depreciation | 4 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 |
Profit before tax | 6 | 2 | 3 | 0 | 1 | 1 | -6 | 1 | 1 | 1 | 6 | 11 | 11 |
Tax % | 9% | 26% | 7% | -425% | 53% | -84% | 11% | 46% | -8% | -1% | 10% | 0% | |
6 | 1 | 3 | 1 | 0 | 1 | -5 | 0 | 1 | 1 | 6 | 11 | 10 | |
EPS in Rs | 0.75 | 0.16 | 0.39 | 0.08 | 0.06 | 0.15 | -0.67 | 0.06 | 0.08 | 0.19 | 0.76 | 1.56 | 1.40 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -27% |
5 Years: | -41% |
3 Years: | -54% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 33% |
3 Years: | 165% |
TTM: | 105% |
Stock Price CAGR | |
---|---|
10 Years: | 29% |
5 Years: | 70% |
3 Years: | 88% |
1 Year: | 113% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 2% |
3 Years: | 3% |
Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 74 | 74 | 74 |
Reserves | 125 | 126 | 129 | 130 | 101 | 102 | 97 | 103 | 104 | 105 | 111 | 122 | 129 |
15 | 42 | 17 | 17 | 17 | 16 | 17 | 12 | 9 | 6 | 29 | 146 | 148 | |
10 | 10 | 13 | 18 | 20 | 66 | 94 | 127 | 133 | 123 | 43 | 38 | 38 | |
Total Liabilities | 194 | 223 | 203 | 210 | 182 | 228 | 253 | 287 | 291 | 278 | 256 | 379 | 389 |
54 | 51 | 49 | 47 | 61 | 55 | 13 | 105 | 135 | 138 | 185 | 179 | 179 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 31 | 0 | 0 | 0 | 0 | 0 |
Investments | 13 | 69 | 69 | 69 | 56 | 56 | 56 | 34 | 34 | 34 | 7 | 136 | 0 |
127 | 103 | 85 | 94 | 65 | 117 | 126 | 117 | 122 | 107 | 65 | 64 | 210 | |
Total Assets | 194 | 223 | 203 | 210 | 182 | 228 | 253 | 287 | 291 | 278 | 256 | 379 | 389 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
7 | 33 | 34 | 1 | 6 | 3 | 18 | 48 | 7 | 11 | 23 | 13 | |
-3 | -56 | -1 | -1 | -3 | -2 | -16 | -39 | -1 | -1 | -42 | -147 | |
-5 | 24 | -31 | -3 | -2 | -2 | -2 | -9 | -7 | -10 | 51 | 103 | |
Net Cash Flow | -0 | 1 | 3 | -3 | 0 | -2 | -0 | 1 | -1 | 0 | 32 | -30 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 327 | 432 | 301 | 437 | 409 | 424 | 610 | 590 | 800 | 626 | 232 | 0 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 327 | 432 | 301 | 437 | 409 | 424 | 610 | 590 | 800 | 626 | 232 | 0 |
Working Capital Days | 856 | 733 | 496 | 537 | 556 | 700 | -315 | -992 | -1,117 | -1,442 | 192 | 6,398 |
ROCE % | 5% | 2% | 4% | 2% | 2% | -3% | -1% | 3% | 3% | 3% | 3% | 8% |
Documents
Announcements
- Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (LODR) Regulations, 2015 16 Apr
- Compliance Certificate As per Regulation 40 (9) And 40 (10) Of The SEBI (LODR) Regulation, 2015 16 Apr
- Board Meeting Outcome for Outcome Of Board Meeting Held On April 12,2024 12 Apr
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 8 Apr
- Clarification And Submission Of Revised Corporate Announcement Of Proceedings Of AGM Of The Company Held On 22.09.2023 Along With Explanation For Delay In Disclosure 8 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
MSL is focused on Pharma, Aerospace and Defense Electronics areas, is in the process of acquiring a few companies, and intend to provide centralized corporate, technology, finance, leadership /management support services to such subsidiaries /associate companies